Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 21, 2020
Product Development

Aducanumab looms larger after Biogen cuts guidance, shelves programs in MS and SMA 

Pressure on aducanumab heats up as Biogen submits an MAA to EMA
BioCentury | May 1, 2019
Translation in Brief

White matter matters in Alzheimer’s

Single-cell transcriptomes reveal myelin role, cell type-specific markers in Alzheimer’s
BioCentury | Feb 12, 2009
Distillery Therapeutics

Indication: Neurology

Items per page:
1 - 5 of 5